Hubbry Logo
CraniotomyCraniotomyMain
Open search
Craniotomy
Community hub
Craniotomy
logo
8 pages, 0 posts
0 subscribers
Be the first to start a discussion here.
Be the first to start a discussion here.
Craniotomy
Craniotomy
Craniotomy
View on Wikipedia
from Wikipedia
Craniotomy
ICD-9-CM01.2
MeSHD003399
eMedicine1890449

A craniotomy is a surgical operation in which a bone flap is temporarily removed from the skull to access the brain. Craniotomies are often critical operations, performed on patients who are suffering from brain lesions, such as tumors, blood clots, removal of foreign bodies such as bullets, or traumatic brain injury, and can also allow doctors to surgically implant devices, such as deep brain stimulators for the treatment of Parkinson's disease, epilepsy, and cerebellar tremor. The procedure is also used in epilepsy surgery to remove the parts of the brain that are causing epilepsy.

Craniotomy is distinguished from craniectomy (in which the skull flap is not immediately replaced, allowing the brain to swell, thus reducing intracranial pressure) and from trepanation, the creation of a burr hole through the cranium into the dura mater.

Procedure

[edit]
Diagram of the elements of a craniotomy.

Human craniotomy is usually performed under general anesthesia but can be also done with the patient awake using a local anaesthetic; the procedure, typically, does not involve significant discomfort for the patient. In general, a craniotomy will be preceded by an MRI scan which provides an image of the human brain (brain in general) that the surgeon uses to plan the precise location for bone removal and the appropriate angle of access to the relevant brain areas. The amount of skull that needs to be removed depends on the type of surgery being performed. The bone flap is mostly removed with the help of a cranial drill and a craniotome, then replaced using titanium plates and screws or another form of fixation (wire, suture, etc.) after completion of the surgical procedure. In the event the host bone does not accept its replacement, an artificial piece of skull, often made of PEEK, is substituted. (The PEEK appliance is routinely modeled by a CNC machine capable of accepting a high resolution MRI computer file in order to provide a very close fit, in an effort to minimize fitment issues, and therefore minimizing the duration of the cranial surgery.)[citation needed]

Complications

[edit]

Bacterial meningitis or viral meningitis occurs in about 0.8 to 1.5% of individuals undergoing craniotomy.[1] Postcraniotomy pain is frequent and moderate to severe in nature. This pain has been controlled through the use of scalp infiltrations, nerve scalp blocks, parecoxib, and morphine, morphine being the most effective in providing analgesia.

According to the Journal of Neurosurgery, Infections in patients undergoing craniotomy: risk factors associated with post-craniotomy meningitis, their clinical studies indicated that "the risk for meningitis was independently associated with perioperative steroid use and ventricular drainage".

Within the 334 procedures that they had conducted from males and females, their results concluded that traumatic brain injuries were the predominant causes of bacterial meningitis.

At least 40% of patients became susceptible to at least one infection, creating more interconnected risk factors along the way. From the Infectious Diseases Clinic Erasme Hospital, there had been reports of infections initially beginning from either the time of surgery, skin intrusion, hematogenous seeding, or retrograde infections.

Cerebrospinal fluid shunt (CSF) associates with the risk of meningitis due to the following factors: pre-shunt associated infections, post-operative CSF leakage, lack of experience from the neurosurgeon, premature birth/young age, advanced age, shunt revisions for dysfunction, and neuroendoscopes.

The way shunts are operated on each patient relies heavily on the cleanliness of the site. Once bacteria penetrates the area of a CSF, the procedure becomes more complicated.

The skin is especially necessary to address because it is an external organ. Scratching the incision site can easily create an infection due to there being no barrier between the open air and wound.

Aside from scratching, decubitus ulcer and tissues near the shunt site are also leading pathways for infection susceptibility.[2]

It is also common to give patients seven days of anti-seizure medications post operatively. Traditionally this has been phenytoin, but now is increasingly levetiracetam as it has a lower risk of drug-drug interactions.[3][4]

See also

[edit]

References

[edit]
[edit]
Revisions and contributorsEdit on WikipediaRead on Wikipedia

Craniotomy

View on Grokipedia
from Grokipedia
A craniotomy is a surgical procedure in which a section of the , known as a bone flap, is temporarily removed to provide access to the for diagnostic or therapeutic interventions. This technique allows neurosurgeons to address various intracranial conditions, such as brain tumors, hematomas, aneurysms, vascular malformations, abscesses, and , while aiming to preserve neurological function, with the bone flap typically replaced at the end of the surgery using plates and screws. Performed under general (or awake in select cases), craniotomy is a cornerstone of , often lasting several hours depending on the complexity of the underlying issue. The practice of craniotomy has ancient origins, dating back to prehistoric times with trephination—drilling holes in the for ritualistic or therapeutic purposes, evidenced as early as 7000 years ago. It was codified for treating fractures by in the 5th century BCE, and modern techniques evolved in the , with Wilhelm Wagner introducing temporary bone flap removal in , leading to contemporary neurosurgical applications.

Introduction and Overview

Definition and Purpose

A craniotomy is a neurosurgical procedure involving the temporary removal of a section of the , known as a bone flap, to provide access to the underlying tissue for therapeutic or diagnostic interventions. This bone flap is typically replaced and secured at the end of the procedure using plates, screws, or other fixation devices, allowing the to heal and resume its protective function. The primary purpose of a craniotomy is to enable surgeons to treat various intracranial pathologies, alleviate elevated , or obtain direct access for biopsies and other diagnostic evaluations. Unlike a craniectomy, in which the removed is not replaced—often to allow for expansion in cases of severe swelling—a craniotomy preserves the structural integrity of the post-surgery. It also differs from trephination, an ancient technique limited to creating a single small hole in the skull via , whereas modern craniotomy involves multiple interconnected burr holes to form a larger, precise flap. The , which the craniotomy targets, consists of dense cortical forming the outer and inner tables separated by a spongy layer called the diploe, providing robust protection to the enclosed while accommodating vascular and neural structures. This layered composition allows surgeons to carefully navigate and preserve vascular supply during flap creation and replacement. In contemporary neurosurgical practice, craniotomies are conducted in specialized operating rooms equipped with advanced and systems, serving both elective procedures for planned interventions and emergency operations to address acute threats.

Historical Development

The practice of craniotomy traces its origins to ancient trepanation, a surgical technique involving the creation of holes in the , evidenced in prehistoric skulls dating back to the period around 10,000 BCE. Archaeological findings reveal healed trephinations in skulls from various regions, including and , indicating that patients often survived the procedure, which was likely performed to treat , relieve , or for spiritual or therapeutic purposes such as exorcising evil spirits. In the 19th century, significant advancements laid the groundwork for modern craniotomy. Joseph Lister introduced antiseptic techniques in 1867, using carbolic acid to reduce postoperative infections, which dramatically lowered mortality rates in cranial surgeries from over 40% to under 3% by the early 20th century. Building on this, Victor Horsley performed the first successful modern neurosurgical craniotomies in the 1880s, including excisions for epilepsy and tumors, establishing neurosurgery as a distinct field. The 20th century brought further milestones in precision and safety. In the 1920s, Harvey Cushing collaborated with William T. Bovie to develop the electrosurgical unit, enabling effective during brain operations and allowing access to previously inoperable tumors by minimizing blood loss. The 1960s saw Mahmut Gazi Yasargil pioneer microneurosurgery by integrating the operative microscope into cranial procedures, enhancing visualization and enabling intricate vascular anastomoses. By the 1970s, stereotactic guidance advanced with the invention of the N-localizer for CT-based targeting, improving accuracy in deep brain interventions. Since the 1990s, craniotomy has evolved toward greater precision and reduced invasiveness. Intraoperative MRI, first implemented in neurosurgical suites in the mid-1990s, allows real-time imaging to guide resections and confirm completeness, particularly for tumors. The 2010s introduced robotic assistance, such as the ROSA system, which provides stereotactic planning and arm guidance for minimally invasive approaches, decreasing incision size and recovery time. Post-2000, the shift to keyhole and endoscopic techniques has further minimized tissue disruption while maintaining efficacy.

Indications

Medical Conditions Requiring Craniotomy

Craniotomy is a critical surgical intervention for numerous medical conditions that compromise integrity. These conditions span oncological, vascular, traumatic, infectious, and other pathologies, where the procedure provides direct access to the to address life-threatening such as , hemorrhage, or . Oncological Conditions
tumors, including gliomas and meningiomas, frequently necessitate craniotomy due to their progressive growth, which exerts on surrounding neural tissue, elevates , and induces neurological deficits like seizures or . The rationale for intervention is tumor resection to achieve , which alleviates symptoms and pressure, or complete removal when feasible for curative intent, particularly in accessible low-grade tumors or metastases. For instance, high-grade gliomas infiltrate parenchyma, compromising function, while meningiomas compress adjacent structures, both requiring surgical access to improve survival and . Vascular Conditions
Vascular anomalies such as cerebral aneurysms and arteriovenous malformations (AVMs) demand craniotomy because of their propensity for rupture, leading to subarachnoid or that causes rapid increases in and potential herniation. Pathophysiologically, weakened vessel walls in aneurysms or abnormal fistulous connections in AVMs disrupt normal blood flow, risking ischemia or bleeding; surgical exposure allows for clipping of aneurysms or resection/ of AVMs to prevent recurrent hemorrhage and stabilize . Traumatic Conditions
Traumatic injuries, particularly those involving subdural or epidural and severe fractures, require urgent craniotomy as accumulated or fragments compress tissue, exacerbating and risking irreversible through ischemia or herniation. The underlying includes vascular disruption from impact, leading to hematoma expansion that elevates ; evacuation via craniotomy relieves this compression, preventing secondary injury and facilitating recovery. Depressed fractures with dural penetration further necessitate intervention to repair breaches and remove foreign bodies. Infectious Conditions
Brain abscesses and subdural empyemas arise from bacterial invasion, forming encapsulated pus collections that expand, increase , and propagate infection to adjacent or , potentially causing or focal deficits. Craniotomy enables thorough drainage and excision of the capsule or empyema, which is essential to eradicate the infectious source, reduce , and allow antibiotic penetration for resolution. For empyemas, wide exposure via craniotomy ensures complete evacuation of purulent material, superior to limited burr hole approaches in complex cases. Other Conditions
In certain complex cases, such as following for post-traumatic , craniotomy may be combined with ventriculoperitoneal shunt placement or revision where excess accumulation dilates ventricles, compressing brain tissue and impairing or motor function. The pathophysiology involves impaired CSF absorption or flow, leading to ex vacuo post-injury; surgical access facilitates shunt insertion to normalize pressure. Craniotomy is also used for decompression in , involving suboccipital bone removal to relieve compression, and for repair of CSF leaks at the base. surgery via craniotomy targets epileptogenic foci in drug-resistant cases, where abnormal neuronal firing circuits cause recurrent s; resection disrupts these pathways to achieve seizure control. Emerging applications include for , where craniotomy provides access for electrode placement in the subthalamic nucleus to modulate dysfunctional circuits, alleviating motor symptoms like bradykinesia.

Diagnostic and Therapeutic Uses

Craniotomy serves as a key procedure in both diagnostic and therapeutic contexts for intracranial , enabling direct access to tissue when non-invasive methods are insufficient. In diagnostic applications, it enables open biopsy for histopathological analysis, particularly for accessible lesions. For less invasive sampling of deep-seated lesions, stereotactic techniques using burr holes and imaging-guided frames or robotic systems precisely target the area, allowing tissue sampling without extensive exposure when imaging alone cannot confirm . This approach is especially valuable for lesions in eloquent areas, minimizing risks while obtaining samples for definitive diagnosis. Therapeutically, craniotomy enables resection of abnormal tissue to alleviate symptoms or halt progression, decompression to mitigate elevated by removing bone and evacuating mass effects, and implantation of devices such as electrodes for seizure monitoring or to manage neurological dysfunction. These interventions aim to restore neurological function or prevent further deterioration, with outcomes influenced by the procedure's ability to achieve complete or partial removal of pathological elements. Decisions to perform craniotomy hinge on factors including lesion accessibility via , comorbidities such as age and overall health status, and a thorough risk-benefit analysis to weigh potential neurological deficits against untreated progression. Tools like the Spetzler-Martin grading scale assess surgical complexity based on size, location, and venous drainage patterns, guiding whether intervention is advisable for specific vascular anomalies. For example, higher-grade lesions may favor conservative management if risks outweigh benefits. Planning for craniotomy typically involves a multidisciplinary team, including neurosurgeons, neurologists, and oncologists, who collaborate to integrate preoperative , functional assessments, and patient-specific goals into a cohesive strategy. This approach ensures optimized outcomes by addressing diagnostic uncertainties and therapeutic objectives holistically.

Types of Craniotomy

Based on Anatomical Location

Craniotomies are classified based on the anatomical location of the targeted, allowing surgeons to access specific intracranial regions while considering the unique vascular supply, venous drainage, and bony landmarks of each area. This approach minimizes damage to surrounding structures, such as major venous sinuses and arteries, which vary by region. For instance, the runs along the midline and must be avoided in anterior and superior exposures, while the , branching from the , poses a risk of hemorrhage near the in lateral approaches. Frontal craniotomies provide access to the and , often used for lesions such as meningiomas in the olfactory groove or planum sphenoidale. The incision typically follows a bicoronal path from the hairline, with burr holes placed near the or orbital rim to create a unilateral or bilateral flap. Anatomical considerations include preserving the frontal branches of the superficial temporal and supraorbital arteries to maintain vascularity, and carefully retracting to avoid injury to the , which can lead to significant bleeding if lacerated. A variant, the orbitofrontal or supraorbital keyhole approach, involves a small incision above the to target anterior lesions like orbitofrontal tumors, reducing tissue disruption while navigating the orbital roof and ethmoidal arteries. Temporal craniotomies, including the common pterional approach, target the middle cranial fossa, temporal lobe, and structures like the cavernous sinus or basilar artery. The incision arcs from the zygomatic arch behind the ear to the hairline, with the bone flap centered at the pterion—the junction of the frontal, temporal, sphenoid, and parietal bones—to expose aneurysms, temporal lobe epilepsy foci, or trigeminal nerve lesions. Key anatomical risks involve the middle meningeal artery, which grooves the inner temporal bone and can cause epidural hematomas if injured during drilling, as well as the vein of Labbé, a major temporal draining vein that, if compromised, may lead to venous infarction of the temporal lobe. This approach also requires caution near the superficial temporal artery to prevent scalp ischemia. Parietal and occipital craniotomies address lesions in the posterior and superior hemispheres, such as parafalcine meningiomas, occipital gliomas, or posterior fossa tumors. For parietal access, a horseshoe incision over the allows a transcortical or interhemispheric route, while occipital exposures use a midline flap from the inion to the vertex. Anatomical specifics include avoiding the along the interhemispheric fissure in parietal approaches, where injury risks , and steering clear of the transverse or sigmoid sinuses in occipital regions to prevent hemorrhage or . The occipital artery supplies the posterior , and its preservation is essential for ; additionally, the vein of Trolard may be encountered in parietal exposures, requiring gentle handling to maintain cortical venous drainage. Suboccipital variants, for posterior fossa access, involve bone removal below the transverse sinus, with risks to the occipital sinus and potential cerebrospinal fluid leaks. Bifrontal craniotomies enable bilateral access to midline anterior structures, such as the , , or sellar region for pituitary adenomas and craniopharyngiomas. The incision spans bicoronally from zygoma to zygoma across the , creating a large flap that reflects both frontal lobes superiorly. Anatomical considerations emphasize bilateral management to avoid or laceration, and minimizing retraction on the frontal lobes to prevent cognitive deficits; vascular supply from paired supraorbital and supratrochlear arteries must be safeguarded bilaterally. Approaches like transcallosal via bifrontal exposure allow interhemispheric access to midline lesions while avoiding deep venous structures such as the vein of Galen.

Based on Surgical Technique

Craniotomies are classified based on surgical techniques that vary in invasiveness, precision, and interaction to optimize access and outcomes for intracranial procedures. Traditional open craniotomy remains the cornerstone for many interventions requiring extensive exposure, while advancements have introduced minimally invasive, , image-guided, and emerging robotic or laser-integrated methods to reduce morbidity and enhance accuracy. These techniques are selected based on characteristics, location, and the need for functional preservation, with each offering distinct advantages in surgical planning and execution. Open craniotomy involves the traditional removal of a full flap to provide wide access to the , allowing for comprehensive resection or intervention in cases such as large tumors or hematomas. This method, dating back to early neurosurgical practices, entails a curvilinear incision, of burr holes, and use of a craniotome to detach a sizable segment, which is stored and later replaced. It is particularly suited for complex demanding broad visualization and manipulation, though it carries risks of and longer recovery due to the larger exposure. Studies indicate that open craniotomy achieves high rates of gross total resection in supratentorial tumors. Minimally invasive craniotomies, such as endoscopic or keyhole approaches, employ smaller incisions and specialized tools to target localized lesions, minimizing tissue disruption and accelerating recovery. The supraorbital keyhole technique, for instance, accesses anterior skull base pathologies through an incision and a narrow corridor, often using endoscopes for visualization of small tumors or aneurysms. This approach reduces hospital stays to 2-4 days compared to 5-7 for open methods and lowers blood loss, with success rates exceeding 90% for select lesions. Endoscopic integration further enhances precision by allowing real-time illumination and within confined spaces. For example, keyhole adaptations can be tailored for frontal access in pituitary or orbital tumors. Awake craniotomy utilizes to maintain patient responsiveness, enabling intraoperative functional mapping of eloquent brain areas like those controlling speech or movement. Direct cortical during the procedure identifies critical zones, guiding resection to maximize tumor removal while preserving , particularly for gliomas near centers. Studies show that this technique can achieve gross total resection rates of approximately 60-90% in eligible cases, with permanent neurological deficits typically under 5% and enhanced survival compared to asleep surgery. It is especially valuable for low-grade gliomas, where mapping correlates with better seizure control and post-resection. Image-guided or stereotactic craniotomies incorporate neuronavigation systems to provide real-time, three-dimensional guidance, enhancing precision without extensive exposure. Frameless stereotaxy, introduced in the , uses optical or electromagnetic tracking of preoperative MRI or CT scans to register patient anatomy, achieving sub-millimeter accuracy for or targeting. This method can reduce operative time compared to traditional approaches and minimizes retraction, with applications in deep-seated tumors where traditional would be riskier. Clinical data show improved diagnostic yields over 95% in stereotactic procedures, making it indispensable for multifunctional navigation in modern . As of 2025, emerging techniques include robotic-assisted craniotomy, exemplified by systems like neuroArm, which offer telesurgical control and haptic feedback for delicate manipulations under MRI guidance. These platforms enable tremor-free movements and integration with imaging for intraoperative adjustments, potentially reducing complications in high-precision tasks such as . Initial clinical series report shorter procedure times and equivalent outcomes to manual methods, with ongoing trials expanding to tumor resections. Additionally, laser interstitial thermal therapy (LITT) is increasingly integrated with craniotomy variants, using stereotactic probes to deliver focused ablation for recurrent or radiation-necrotized lesions, achieving local control rates comparable to open resection while avoiding full flaps in select cases. Guidelines now endorse LITT post-stereotactic radiosurgery for brain metastases, highlighting its role in minimizing steroid dependence and hospitalization.

Preoperative Preparation

Patient Evaluation

Patient evaluation prior to craniotomy involves a comprehensive assessment to determine surgical candidacy, optimize status, and stratify risks. This process begins with a detailed , including prior surgeries, anesthesia complications, allergies, medication use (particularly anticoagulants and antiplatelets), , alcohol or habits, and history of coagulopathies. The physical examination evaluates overall , airway patency (considering cervical stability), volume status, and lower cranial nerve function to identify aspiration risks. A thorough is essential, assessing level of consciousness, motor and sensory deficits, cranial nerve integrity (e.g., pupil response and function), and using the (GCS) to quantify neurological status, with scores below 7 often necessitating . Comorbidities such as , , or are screened, with antiplatelet agents like aspirin potentially continued while clopidogrel is withheld 10 days preoperatively to minimize bleeding risks. Laboratory testing supports this evaluation by identifying correctable abnormalities that could impact perioperative outcomes. Routine tests include a (CBC) to assess levels (targeting of 30-33% for optimal oxygen delivery) and white cell count for infection risk, electrolytes to detect imbalances affecting neurological function, and coagulation profile ( [PT], international normalized ratio [INR], [PTT], and platelet count) especially in patients on antithrombotic therapy. Additional studies, such as electrocardiogram (ECG) for cardiac risks and chest if pulmonary issues are present, may be ordered based on history. Blood typing and cross-matching are prepared for potential transfusions. Risk stratification employs tools like the physical status classification to categorize patients from I (healthy) to VI (brain-dead), guiding perioperative management and predicting complications. Frailty indices assess vulnerability in elderly or comorbid patients, while contraindications such as uncontrolled , severe , or moribund state may delay elective procedures. High-risk factors like advanced age or poor functional status warrant multidisciplinary clearance from or . Informed consent is obtained after discussing the procedure's risks (e.g., , , neurological deficits), benefits, alternatives (e.g., conservative management or ), and potential outcomes, tailored to the patient's capacity; proxy consent is used if is impaired. This ensures patients understand the implications, with emphasis on optimizing modifiable risks preoperatively.

Surgical Planning and Imaging

Surgical planning for craniotomy begins with advanced imaging modalities to precisely localize lesions and map critical brain structures, ensuring maximal safe resection while minimizing risks to eloquent areas. Computed tomography (CT) and are foundational for delineating tumor boundaries, anatomy, and potential entry points, with preoperative MRI particularly enabling accurate registration for neuronavigation systems. In cases involving brain tumors such as gliomas or meningiomas, these modalities provide high-resolution visualization of lesion extent and surrounding tissues, guiding craniotomy placement with initial registration errors below 2 mm. Functional MRI (fMRI) plays a crucial role in mapping eloquent cortical areas, such as language and motor regions, to avoid postoperative deficits during tumor resections. Commonly applied paradigms include language tasks (used in 83.9% of cases) and motor assessments (75.0%), which help tailor the surgical approach in 75% of patients proceeding to craniotomy. For vascular-related procedures, preoperative CT-angiography (CTA) or digital subtraction angiography identifies dural sinuses, aneurysms, and feeding vessels relative to bony landmarks, reducing risks of hemorrhage or embolism by providing clear 3D vascular maps with minimal added morbidity. These imaging techniques collectively inform trajectory selection and incision planning, often integrating data from multiple sequences to account for patient-specific anatomy. Planning tools further refine the procedure through and neuronavigation software, enabling virtual simulation of surgical paths. Systems like VectorVision facilitate frameless, image-guided navigation, achieving mean target localization accuracy of 1.15 mm across 420 cases, including deep-seated gliomas and skull base lesions. and modeling from MRI/CT data create patient-specific replicas of pathologies, such as vascular anomalies or tumors, allowing preoperative rehearsal of bone flap removal and tissue dissection to identify anatomic variations and optimize clip placement. models, including augmented and platforms, enhance spatial understanding for complex approaches like pterional or retrosigmoid craniotomies, improving decision-making on entry points and neurovascular avoidance. Multidisciplinary input, particularly from tumor boards, integrates findings with , , and treatment options to finalize plans. These boards discuss diagnostic interpretations and surgical strategies, with 100% of participants reporting high benefit for treatment planning in cases, relying on expert consensus, , and clinical guidelines. Recent advances as of 2025 incorporate (AI) for automated trajectory planning, using on preoperative MRI to simulate craniotomy paths that maximize tumor resection (e.g., 92.31% success rate in cases) while preserving function. Integration of intraoperative with preoperative is also evolving in planning workflows, providing real-time validation models to anticipate brain shift and refine simulations preoperatively.

Surgical Procedure

Anesthesia and Positioning

Craniotomy procedures typically require general anesthesia to ensure patient immobility, airway protection, and hemodynamic stability, achieved through endotracheal intubation and intravenous agents such as propofol for induction and maintenance alongside remifentanil for analgesia. In contrast, awake craniotomy employs monitored anesthesia care (MAC) or asleep-awake-asleep (AAA) techniques, utilizing scalp blocks for local anesthesia and sedatives like dexmedetomidine or low-dose propofol/remifentanil infusions to allow intraoperative neurological assessment while minimizing respiratory depression. Awake approaches are particularly selected for tumors near eloquent brain areas to facilitate real-time functional mapping. Intraoperative monitoring is integral to anesthesia management, with (EEG) used to achieve patterns during general anesthesia for in cases of high or ischemia risk, indicating deep anesthetic levels through alternating high-amplitude bursts and flat suppression periods. Neuromonitoring modalities, including somatosensory evoked potentials (SSEPs) and motor evoked potentials (MEPs), assess sensory and motor pathway integrity, respectively, with MEPs being more sensitive to volatile anesthetics and requiring total intravenous anesthesia to maintain reliable signals. Patient positioning varies by surgical site: supine for frontal or temporal access, lateral (park-bench) for parietal or occipital lesions, and prone for posterior fossa approaches, all with the head elevated 15-30 degrees to optimize venous drainage and reduce . The head is secured in a Mayfield three-pin skull clamp to provide rigid fixation, applied after induction to avoid pin-site complications, with careful attention to limiting neck rotation beyond 30 degrees to preserve jugular venous outflow. Prophylactic measures include intravenous (2 g dose) administered within 60 minutes of incision to prevent surgical site infections from , as supported by guidelines recommending its use for clean neurosurgical procedures. prophylaxis, such as (4 mg IV) combined with dexamethasone, is routinely given to mitigate , which occurs in up to 45% of craniotomy patients due to and vestibular manipulation.

Incision and Bone Flap Removal

The incision in a craniotomy is meticulously planned to ensure adequate exposure of the surgical site while preserving cosmetic appearance and neurovascular structures. Common incision types include curvilinear designs, such as the pterional incision centered on the to access the anterior and middle cranial fossae, and linear incisions like the retrosigmoid approach for posterior fossa lesions. These incisions are typically placed behind the hairline to minimize visible scarring and avoid major vessels, such as the in pterional approaches. Following the incision, the scalp is reflected as a vascularized flap to expose the underlying temporalis muscle and skull. In curvilinear incisions like the bicoronal or horseshoe flap, the scalp is elevated anteriorly or posteriorly using self-retaining retractors or silk sutures fixed to the skin edges, with the pericranium often separated to serve as a potential dural substitute if needed. Hemostasis along the incision margins is secured early with bipolar cautery to prevent intraoperative bleeding. This reflection step is guided by neuronavigation systems to enhance precision and limit tissue trauma. Key tools for bone flap removal include high-speed pneumatic or electric drills equipped with perforators for creating initial burr holes, followed by a craniotome—a footplate-protected saw—for connecting the holes and outlining the flap. The , a flexible , serves as a manual alternative to the craniotome, particularly useful for navigating inner bony ridges in frontobasal or pterional craniotomies without powered instrumentation. Dural protection is paramount during drilling; a malleable retractor or Penfield dissector is placed beneath the dura to shield it from the , while liberal hitch stitches elevate the dura to reduce tension and bleeding risk. Bone flap creation involves drilling 3–5 burr holes in a curvilinear or pattern, spaced 2–3 cm apart, using a Hudson brace or motorized perforator to penetrate the tables without breaching the inner table excessively. The craniotome then cuts between holes, beveling the edges outward to prevent the flap from sinking upon replacement, while avoiding dural tears through constant irrigation and visual confirmation. Post-flap elevation, bone edge hemostasis is achieved with bipolar cautery and to seal . Patient positioning, such as with head rotation for pterional access, briefly influences incision alignment to optimize gravitational retraction of tissues. Technique variations enhance safety and precision in specific scenarios; burr holes provide initial entry points that are enlarged with a rongeur or for small flaps, as in keyhole craniotomies. Piezo-surgery, utilizing ultrasonic microvibrations, offers a modern alternative for bone cutting, selectively targeting mineralized tissue with minimal thermal spread or vibration to adjacent soft structures like dura or vessels, reducing the risk of inadvertent injury in delicate areas such as orbital or transsphenoidal approaches.

Brain Access and Intervention

Once the bone flap has been removed, the surgeon incises the , the protective membrane covering the , typically using a cruciate incision to create intersecting cuts that allow for controlled opening and maximal exposure of the underlying tissue. Tenting sutures are then placed through small holes in the edges to elevate and secure the dural flaps, preventing collapse onto the surface and facilitating better visualization and access during the procedure. With the brain exposed, the specific intervention targets the underlying pathology. For tumor resection, the surgeon meticulously removes the lesion while preserving surrounding healthy tissue, often employing intraoperative ultrasound to delineate tumor margins and confirm the extent of resection in real-time, which enhances the completeness of removal particularly in gliomas. In cases of intracranial hematoma, evacuation involves gentle aspiration and irrigation of the accumulated blood to relieve pressure on the brain, using suction and hemostatic techniques to achieve a dry field. For cerebral aneurysms, the surgeon applies a microsurgical clip across the aneurysm neck to isolate it from circulation and prevent rupture, ensuring patency of adjacent vessels. Several adjunct technologies are routinely integrated to improve precision and safety. The operating microscope provides high-magnification illumination and stereoscopic visualization of delicate neurovascular structures, enabling fine dissection. Intraoperative navigation systems, akin to GPS, overlay preoperative imaging onto the surgical field in real-time, guiding instrument placement and accounting for brain shift during the operation. For high-grade gliomas, 5-aminolevulinic acid (5-ALA) is administered preoperatively, causing tumor cells to emit pink-red fluorescence under blue light, which aids in identifying residual malignant tissue beyond what is visible to the naked eye. The duration of this intracranial phase varies with procedural complexity but typically ranges from 2 to 6 hours, encompassing , intervention, and before proceeding to closure. In select cases involving eloquent brain areas, techniques such as awake mapping may be briefly employed to monitor neurological function during resection.

Closure and Reconstruction

Following the completion of the intracranial intervention, meticulous is achieved to control any residual bleeding from dural edges, bone surfaces, or soft tissues, using agents such as for and oxidized regenerated cellulose (e.g., ) for parenchymal oozing, ensuring a dry field before proceeding to closure. The surgical site is then irrigated copiously with warm saline solution to remove debris, clots, and potential contaminants, thereby reducing the risk of postoperative . The is closed in a watertight manner to prevent () leakage, typically using interrupted or running sutures with absorbable materials like 4-0 polyglactin (), applied without excessive tension to avoid tearing; if primary closure is not feasible due to dural defects or resection, synthetic substitutes such as matrices or pericardial patches are employed to achieve a secure seal. Epidural tacking sutures may be placed to secure the dura against the bone edges, minimizing dead space and formation. The bone flap is then repositioned and secured to restore skull integrity, most commonly fixed with titanium plates and screws for rigid immobilization, allowing for precise alignment and promoting osseous healing; in cases requiring custom reconstruction, such as large defects or irregular contours, synthetic implants made from polyetheretherketone (PEEK) are used for their biocompatibility, radiolucency, and ability to be molded to patient-specific anatomy via preoperative imaging. Finally, the scalp is closed in layers to ensure a tension-free : the galea aponeurotica is sutured with absorbable monofilament (e.g., 3-0 PDS), followed by interrupted sutures to preserve vascularity, and the skin is closed with staples or non-absorbable sutures like for cosmetic and secure healing. Subgaleal or subdural drains are often placed to evacuate potential CSF accumulation or , connected to a closed suction system and removed once output is minimal (typically <30 mL per 24 hours).

Postoperative Care

Immediate Recovery

Following craniotomy, patients are typically transferred directly from the operating room to a recovery area or the neurosurgical (neuro-ICU) for initial stabilization, particularly in high-risk cases involving significant manipulation, , or comorbidities, where close monitoring is essential to detect early deterioration. In the neuro-ICU, continuous monitoring—including , , , and —is initiated to maintain hemodynamic stability and prevent secondary injury. Initial neurological assessments are performed frequently, often every 15 to 60 minutes in the first few hours, to evaluate key indicators such as level of consciousness, pupil reactivity, motor function in the extremities, and sensory responses, allowing for prompt intervention if changes occur. These checks compare against preoperative baselines to identify any new deficits. Supportive care in this period focuses on weaning from if the patient was intubated, typically within hours if stable, transitioning to supplemental oxygen via mask as needed; intravenous fluids are administered to ensure hydration and electrolyte balance, while a nasogastric tube may be placed temporarily for gastric decompression or feeding if , , or difficulties arise. Early mobilization is encouraged for stable patients, with sitting up in bed often initiated within 24 hours to promote circulation and reduce the risk of complications like deep vein thrombosis, progressing to assisted walking under supervision. protocols, involving multimodal analgesia such as acetaminophen and opioids, are implemented to facilitate comfort and participation in these activities. By 24 to 48 hours, if and neurological status remain stable, transfer to a step-down unit or ward may occur, marking the transition from immediate intensive recovery.

Monitoring and Pain Management

In the acute postoperative period following craniotomy, patients are typically admitted to an for close neurological surveillance to detect early signs of deterioration. Serial assessments of the (GCS) are performed frequently, often every 1-2 hours initially, to evaluate level of consciousness, motor function, and pupillary responses. Intracranial pressure (ICP) monitoring via an external bolt or drain is indicated if clinical signs suggest elevation, with intervention thresholds commonly set at 20-25 mmHg to prevent secondary brain injury. Seizure prophylaxis is a standard component of care due to the risk of early postoperative seizures, with levetiracetam administered as the preferred agent. Typical dosing involves a loading dose of 1000 mg followed by maintenance of 500-1000 mg twice daily (BID) for 7 days postoperatively, balancing efficacy against minimal neurotoxicity. Pain management employs a multimodal strategy to optimize analgesia while minimizing opioid-related side effects that could confound neurological assessments. Acetaminophen is routinely given pre- and postoperatively for its opioid-sparing effects, combined with patient-controlled analgesia (PCA) using short-acting opioids such as fentanyl for breakthrough pain. Regional scalp nerve blocks, targeting nerves like the supraorbital and greater occipital, provide effective localized relief and reduce overall opioid requirements in the early recovery phase. Hemodynamic stability is maintained through continuous monitoring, targeting a (MAP) greater than 70 mmHg to ensure adequate without exacerbating or hemorrhage. imbalances, particularly from syndrome of inappropriate antidiuretic hormone secretion or cerebral salt wasting, are promptly corrected using hypertonic saline or fluid restriction to avoid complications like seizures or .

Complications and Risks

Intraoperative Complications

Intraoperative complications during craniotomy encompass a range of risks that can arise during the surgical procedure, potentially leading to hemodynamic instability, neurological deficits, or procedural interruptions if not promptly managed. These events are influenced by factors such as patient comorbidities, tumor location, and , with vigilant monitoring and multidisciplinary coordination essential for mitigation. Bleeding represents one of the most immediate threats, often resulting from vascular injury, such as tears in dural sinuses or bridging veins encountered during bone flap removal or brain exposure. Such injuries can cause significant blood loss, leading to hypotension and reduced cerebral perfusion if not controlled swiftly. Management typically involves direct compression with hemostatic agents like thrombin-soaked Gelfoam packing, bipolar electrocauturation for vessel coagulation, and administration of coagulation factors or antifibrinolytics such as tranexamic acid to stabilize the clot and minimize further hemorrhage. Brain injury from intraoperative swelling or herniation may occur due to excessive retraction, manipulation of eloquent areas, or underlying exacerbated by surgical trauma. Retraction-related pressure can elevate , risking transtentorial or uncal herniation, which manifests as pupillary changes or Cushing's triad. To achieve brain relaxation and counteract swelling, hyperosmolar therapy with at a dose of 0.5-1 g/kg is commonly employed, drawing fluid from brain tissue into the vascular space to reduce without compromising cerebral blood flow. Intraoperative infections are uncommon, primarily stemming from breaches in the sterile field, such as inadvertent during or prolonged exposure of the surgical site. Strict adherence to aseptic protocols, including prophylactic antibiotics and , minimizes this risk, with immediate and used if is suspected to prevent progression to deeper . Anesthesia-related complications include hypotension from blood loss or vasodilatory agents, and venous air embolism particularly in the sitting or semi-sitting position for posterior fossa procedures, where negative pressure gradients allow air entry into venous sinuses. Air embolism presents with sudden end-tidal CO2 drop, mill-wheel murmur, or desaturation, managed by flooding the field with saline, aspirating via central line, and supporting hemodynamics with vasopressors. In awake craniotomy variants, anesthesia risks may also involve transient neurological monitoring challenges, though conversion to general anesthesia remains rare. Overall, intraoperative mortality during craniotomy is low, estimated at less than 1% in modern series, reflecting advances in neuromonitoring, hemostatic techniques, and anesthetic care, though rates can vary with case complexity.

Postoperative Complications

Postoperative complications following craniotomy can arise from surgical trauma, patient factors, or procedural aspects, with representing one of the most common issues. Surgical site infections occur in 1-10% of cases, encompassing wound infections and deeper involvement such as or abscesses. , often linked to (CSF) leaks, carries a risk of 1-2% and presents with symptoms including fever, , nuchal rigidity, and altered mental status; CSF leaks manifest as clear or otorrhea and increase infection susceptibility by providing a pathway for bacterial entry. Prophylactic antibiotics, such as or for methicillin-resistant Staphylococcus aureus coverage, are routinely administered perioperatively to mitigate these risks, reducing overall rates from approximately 9.7% to 5.8%. Neurological complications include and seizures, which can exacerbate morbidity if not promptly managed. Postoperative brain , resulting from surgical manipulation and blood-brain barrier disruption, is treated with corticosteroids like dexamethasone at a dose of 4 mg every 6 hours to reduce vasogenic swelling and alleviate symptoms such as or neurological deficits. Seizures occur in up to 20-30% of patients post-craniotomy, particularly in those with supratentorial lesions; while short-term prophylaxis with antiepileptic drugs (AEDs) such as (1,000-2,000 mg daily) is common to prevent early-onset events, breakthrough seizures beyond this period may require dose adjustment or alternative AEDs like . Systemic complications, such as venous thromboembolism (VTE) and , stem largely from immobility and hypercoagulability in the postoperative period. VTE, including deep vein thrombosis and , affects 2-10% of patients after craniotomy, with higher rates in those with brain tumors due to malignancy-associated ; prevention involves mechanical methods like devices initiated immediately post-surgery, alongside pharmacologic prophylaxis (e.g., ) delayed 24-72 hours to minimize hemorrhage risk. develops in about 3% of cases, often from aspiration or ventilator dependence in immobile patients, and is managed through early mobilization, incentive , and respiratory support. Bone flap-related issues, particularly with autologous grafts, include and resorption, potentially necessitating removal and revision . Bone flap infections occur in 1-5% of cases, presenting as erythema, drainage, or , and often require flap removal, , and antibiotics; risk factors include prior or delayed reimplantation. Resorption of the autologous bone flap affects 10-20% of pediatric and adult patients, characterized by progressive visible on , and is more common in younger individuals or after decompressive procedures, sometimes leading to cosmetic or neurological symptoms that mandate synthetic replacement. Late complications, such as hydrocephalus, may emerge weeks to months post-resection, particularly after tumor removal or decompressive craniotomy. As of 2025 data, hydrocephalus develops in 6-36% of cases following decompressive craniectomy for trauma, driven by impaired CSF absorption from subarachnoid hemorrhage or adhesions; symptoms include gait disturbance, incontinence, and cognitive decline, often requiring ventriculoperitoneal shunting for management. Early detection through serial imaging aids in timely intervention to prevent irreversible ventricular enlargement.

Recovery and Long-term Outcomes

Rehabilitation Process

The rehabilitation process following a craniotomy typically begins in the inpatient setting around days 3 to 7 post-surgery, transitioning to outpatient care upon discharge to address deficits arising from neurosurgical intervention. This structured approach aims to restore function and independence, tailored to the patient's specific impairments, such as motor weaknesses or cognitive changes resulting from the procedure's location. Inpatient (PT) and (OT) are initiated early, focusing on mobility and daily activities. PT emphasizes exercises, muscle strengthening, balance training, and to combat or coordination issues common after craniotomy. OT targets upper extremity function and (ADLs), such as dressing and , to promote independence. is incorporated for patients experiencing or swallowing difficulties, using targeted exercises to improve communication and oral motor skills. Cognitive rehabilitation forms a key component, particularly for or executive function deficits, as seen in craniotomies. Techniques include aids, exercises, and problem-solving tasks integrated into OT sessions to enhance cognitive processing. Physical rehabilitation specifically addresses through resistive exercises and endurance training, helping patients regain strength on the affected side. A multidisciplinary team, including neuropsychologists, physical and occupational therapists, speech-language pathologists, and specialists, collaborates to create individualized plans. Neuropsychologists assess and treat cognitive and emotional changes, while supports return to work through skill-building. Home modifications, such as installing grab bars or adaptive equipment, are recommended to facilitate safe reintegration into daily life. The process generally spans 3 to 6 months, beginning with a stay of 3-7 days, followed by outpatient rehabilitation. Milestones include achieving independent walking, typically within the first few weeks of PT, and progressing to unsupervised ADLs by the end of the initial month. Complications like infections can delay this timeline by interrupting sessions.

Prognosis and Follow-up

The prognosis following craniotomy varies significantly depending on the underlying condition, patient factors, and whether the procedure is elective or emergent. For elective craniotomies, the 30-day is approximately 0.55%, translating to a exceeding 99% in well-selected patients across age groups. Overall outcomes improve with maximal resection, but differ by ; recent studies (as of 2025) report 5-year of 80-90% or higher for low-grade gliomas treated via craniotomy with adjuvant therapies. In contrast, more aggressive tumors such as high-grade gliomas yield poorer long-term , often below 10% at 5 years despite surgical intervention. Follow-up care is essential for monitoring recovery, detecting recurrence, and managing adjuvant therapies. Patients typically undergo serial MRI scans starting 3-6 months post-surgery, with intervals of every 3-6 months for the first 5 years in cases of high-grade tumors, and every 6-12 months for low-grade tumors, alongside regular clinical visits to assess neurological status. Adjuvant or is often integrated based on tumor , with protocols tailored to enhance disease control; for low-grade gliomas, such multimodal approaches can further improve 5-year survival to over 90% in recent cohorts. Rehabilitation plays a supportive role in optimizing functional recovery during this period. Quality of life post-craniotomy is commonly evaluated using the Karnofsky Performance Scale (KPS), where preoperative scores above 70 correlate with better long-term functional independence and survival. Younger age, particularly under 65 years, is a favorable prognostic factor, reducing the risk of meaningful functional decline by up to twofold compared to patients over 75. Advances in personalized medicine, including genomic profiling of tumors, have emerged by 2025 to refine prognosis predictions; for example, identifying specific mutations like IDH1 enables targeted therapies such as vorasidenib, which significantly extend progression-free survival in IDH-mutant gliomas (as of 2025).

References

  1. https://www.ncbi.nlm.nih.gov/books/NBK560922/
  2. https://www.mayoclinic.org/tests-procedures/craniotomy/about/pac-20568981
  3. https://www.urmc.rochester.edu/encyclopedia/content?contentid=P08767&contenttypeid=92
  4. https://pmc.ncbi.nlm.nih.gov/articles/PMC2640049/
  5. https://pmc.ncbi.nlm.nih.gov/articles/PMC3876527/
  6. https://pmc.ncbi.nlm.nih.gov/articles/PMC4427816/
  7. https://pmc.ncbi.nlm.nih.gov/articles/PMC9854334/
  8. https://academic.oup.com/brain/article/139/2/631/1753767
  9. https://pubmed.ncbi.nlm.nih.gov/8644002/
  10. https://www.eans.org/news/703270/In-Memoriam-Professor-M.-Gazi-Yaargil-1925-2025.htm
  11. https://pubmed.ncbi.nlm.nih.gov/22186842/
  12. https://pmc.ncbi.nlm.nih.gov/articles/PMC2902263/
  13. https://www.researchgate.net/publication/308390639_Evaluation_of_the_ROSA_Spine_robot_for_minimally_invasive_surgical_procedures
  14. https://pmc.ncbi.nlm.nih.gov/articles/PMC3877623/
  15. https://my.clevelandclinic.org/health/treatments/24902-craniotomy
  16. https://pmc.ncbi.nlm.nih.gov/articles/PMC3622376/
  17. https://pubmed.ncbi.nlm.nih.gov/11564248/
  18. https://pmc.ncbi.nlm.nih.gov/articles/PMC9852628/
  19. https://pubmed.ncbi.nlm.nih.gov/25448200/
  20. https://www.mayoclinic.org/diseases-conditions/chiari-malformation/diagnosis-treatment/drc-20354013
  21. https://www.mayoclinic.org/tests-procedures/epilepsy-surgery/about/pac-20393981
  22. https://pmc.ncbi.nlm.nih.gov/articles/PMC3382386/
  23. https://www.aans.org/patients/conditions-treatments/stereotactic-brain-biopsy/
  24. https://www.hopkinsmedicine.org/health/treatment-tests-and-therapies/craniotomy
  25. https://www.mayoclinic.org/diseases-conditions/brain-tumor/diagnosis-treatment/drc-20350088
  26. https://pmc.ncbi.nlm.nih.gov/articles/PMC10927046/
  27. https://www.urmc.rochester.edu/cancer-institute/cancers/brain-spine/multidisciplinary-care/neurosurgery/treatments/craniotomy
  28. https://www.ahajournals.org/doi/10.1161/01.cir.103.21.2644
  29. https://pmc.ncbi.nlm.nih.gov/articles/PMC6896626/
  30. https://pmc.ncbi.nlm.nih.gov/articles/PMC6836570/
  31. https://www.mayoclinic.org/medical-professionals/ophthalmology/news/collaborative-surgical-innovation-can-reduce-complications-and-hospital-stay/mac-20561320
  32. https://pmc.ncbi.nlm.nih.gov/articles/PMC7771396/
  33. https://mayfieldclinic.com/pe-craniotomy.htm
  34. https://www.mayoclinic.org/tests-procedures/keyhole-craniotomy/about/pac-20585909
  35. https://www.pacificneuroscienceinstitute.org/brain-tumor/treatment/minimally-invasive-brain-surgery/
  36. https://www.nejm.org/doi/full/10.1056/NEJMoa067819
  37. https://pubmed.ncbi.nlm.nih.gov/32311556/
  38. https://pmc.ncbi.nlm.nih.gov/articles/PMC3563325/
  39. https://www.sciencedirect.com/topics/medicine-and-dentistry/frameless-stereotactic-procedure
  40. https://schulich.ucalgary.ca/biomedical/research/research-areas/novel-medical-technologies/neuroarm
  41. https://neuroarm.org/
  42. https://www.sciencedirect.com/science/article/pii/S2405844024163955
  43. https://www.sciencedirect.com/science/article/pii/S1878875024017145
  44. https://www.cancernetwork.com/view/guideline-update-supports-laser-therapy-for-brain-tumors-after-srs
  45. https://www.neurosurgicalatlas.com/volumes/principles-of-cranial-surgery/preoperative-evaluation
  46. https://pmc.ncbi.nlm.nih.gov/articles/PMC2911602/
  47. https://emedicine.medscape.com/article/1890449-periprocedure
  48. https://pubmed.ncbi.nlm.nih.gov/25429625/
  49. https://pubmed.ncbi.nlm.nih.gov/28004630/
  50. https://pubmed.ncbi.nlm.nih.gov/9766331/
  51. https://pubmed.ncbi.nlm.nih.gov/17041831/
  52. https://pubmed.ncbi.nlm.nih.gov/26724615/
  53. https://pubmed.ncbi.nlm.nih.gov/39081485/
  54. https://pubmed.ncbi.nlm.nih.gov/21882052/
  55. https://pubmed.ncbi.nlm.nih.gov/40889518/
  56. https://www.ncbi.nlm.nih.gov/books/NBK572053/
  57. https://pmc.ncbi.nlm.nih.gov/articles/PMC7713838/
  58. https://pmc.ncbi.nlm.nih.gov/articles/PMC8330552/
  59. https://pmc.ncbi.nlm.nih.gov/articles/PMC11026914/
  60. https://aneskey.com/positioning-in-neurosurgery/
  61. https://pmc.ncbi.nlm.nih.gov/articles/PMC2265668/
  62. https://emedicine.medscape.com/article/1890449-medication
  63. https://pmc.ncbi.nlm.nih.gov/articles/PMC8195733/
  64. https://www.neurosurgery.columbia.edu/patient-care/treatments/craniotomy
  65. https://pubmed.ncbi.nlm.nih.gov/11013628/
  66. https://pmc.ncbi.nlm.nih.gov/articles/PMC7357104/
  67. https://pmc.ncbi.nlm.nih.gov/articles/PMC3933521/
  68. https://neupsykey.com/general-craniotomy-techniques/
  69. https://pmc.ncbi.nlm.nih.gov/articles/PMC6367978/
  70. https://pmc.ncbi.nlm.nih.gov/articles/PMC5226862/
  71. https://www.nejm.org/doi/full/10.1056/NEJMoa2214172
  72. https://www.hopkinsmedicine.org/health/treatment-tests-and-therapies/microsurgical-clipping-for-brain-aneurysms
  73. https://pmc.ncbi.nlm.nih.gov/articles/PMC7780882/
  74. https://www.brainlab.com/surgery-products/overview-neurosurgery-products/cranial-navigation/
  75. https://pmc.ncbi.nlm.nih.gov/articles/PMC7707111/
  76. https://pmc.ncbi.nlm.nih.gov/articles/PMC10198091/
  77. https://pmc.ncbi.nlm.nih.gov/articles/PMC9204918/
  78. https://pmc.ncbi.nlm.nih.gov/articles/PMC7066100/
  79. https://pmc.ncbi.nlm.nih.gov/articles/PMC3596491/
  80. https://www.cancerresearchuk.org/about-cancer/brain-tumours/treatment/surgery/after-surgery
  81. https://pmc.ncbi.nlm.nih.gov/articles/PMC9838367/
  82. https://thejns.org/view/journals/j-neurosurg/135/6/article-p1857.xml
  83. https://www.ncbi.nlm.nih.gov/books/NBK326713/
  84. https://www.neurology.org/doi/10.1212/WNL.96.15_supplement.4877
  85. https://pubmed.ncbi.nlm.nih.gov/36156532/
  86. https://pubmed.ncbi.nlm.nih.gov/31306155/
  87. https://pubmed.ncbi.nlm.nih.gov/27604271/
  88. https://emcrit.org/ibcc/crani/
  89. https://pmc.ncbi.nlm.nih.gov/articles/PMC6906102/
  90. https://www.uptodate.com/contents/anesthesia-for-craniotomy-in-adults
  91. https://www.frontiersin.org/journals/neurology/articles/10.3389/fneur.2024.1371184/full
  92. https://surgicalneurologyint.com/surgicalint-articles/tranexamic-acid-to-reduce-operative-blood-loss-in-brain-tumor-surgery-a-meta-analysis/
  93. https://www.frontiersin.org/journals/neurology/articles/10.3389/fneur.2023.1196431/full
  94. https://thejns.org/view/journals/j-neurosurg/126/6/article-p1839.xml
  95. https://pmc.ncbi.nlm.nih.gov/articles/PMC4018619/
  96. https://www.dovepress.com/risk-factors-for-central-nervous-system-infections-after-craniotomy-peer-reviewed-fulltext-article-JMDH
  97. https://pmc.ncbi.nlm.nih.gov/articles/PMC10739228/
  98. https://pmc.ncbi.nlm.nih.gov/articles/PMC11215929/
  99. https://www.bjaed.org/article/S1743-1816%2817%2930079-3/fulltext
  100. https://www.frontiersin.org/journals/neurology/articles/10.3389/fneur.2023.1153392/full
  101. https://pmc.ncbi.nlm.nih.gov/articles/PMC10809023/
  102. https://link.springer.com/article/10.1007/s00701-024-06193-w
  103. https://pmc.ncbi.nlm.nih.gov/articles/PMC9615103/
  104. https://www.tandfonline.com/doi/abs/10.1080/02688690500145639
  105. https://pubmed.ncbi.nlm.nih.gov/30639502/
  106. https://pmc.ncbi.nlm.nih.gov/articles/PMC6494638/
  107. https://www.frontiersin.org/journals/neurology/articles/10.3389/fneur.2025.1543905/full
  108. https://pmc.ncbi.nlm.nih.gov/articles/PMC6609511/
  109. https://journal.chestnet.org/article/S0012-3692%2815%2950808-8/abstract
  110. https://www.sciencedirect.com/science/article/abs/pii/S0195670120301146
  111. https://sjtrem.biomedcentral.com/articles/10.1186/s13049-015-0155-6
  112. https://pmc.ncbi.nlm.nih.gov/articles/PMC4847489/
  113. https://thejns.org/view/journals/j-neurosurg/130/1/article-p312.xml
  114. https://pmc.ncbi.nlm.nih.gov/articles/PMC12182525/
  115. https://link.springer.com/article/10.1007/s44411-024-00003-6
  116. https://www.physio-pedia.com/Craniotomy
  117. https://pmc.ncbi.nlm.nih.gov/articles/PMC6509576/
  118. https://thejns.org/view/journals/j-neurosurg/134/4/article-p1113.xml
  119. https://www.thebraintumourcharity.org/news/research-news/researchers-announce-staggering-increase-glioma-su/
  120. https://www.nature.com/articles/s41598-025-95693-5
  121. https://www.cancerresearchuk.org/about-cancer/brain-tumours/survival
  122. https://cancer.ca/en/cancer-information/cancer-types/brain-and-spinal-cord/treatment/follow-up
  123. https://www.sciencedirect.com/topics/nursing-and-health-professions/karnofsky-performance-status
  124. https://pmc.ncbi.nlm.nih.gov/articles/PMC9560674/
  125. https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(23)00472-3/fulltext
  126. https://www.nejm.org/doi/full/10.1056/NEJMoa2304194
Add your contribution
Related Hubs
User Avatar
No comments yet.